About this role
AGC Biologics is seeking for a highly motivated and detail-oriented Student Assistant to join our Quality Assurance (QA) team for Manufacturing Support.
You will get a chance to learn and develop from day one!
You will be given the following tasks and responsibilities:
- Scanning and archiving of Quality Records.
- QA review of Media and Buffer Sheets.
- Ad-hoc tasks, i.e. MPR print, overview of media and buffers approved by QA.
We are looking for a detail-oriented bachelor's student!
The ideal candidate would be currently enrolled in science-related degree, and preferably at bachelor' level. The work environment of AGC Biologics can be fast-paced and dynamic, so we are looking for someone who thrives in this. Further, we are looking for a person with:
- Strong attention to detail and sense of quality.
- Ability to work independently and as part of a team.
- Have a strong can-do attitude.
- Proficient in Microsoft Office, especially Excel and Word.
- Prior experience in a GMP-regulated environment preferred.
Apply today and join an amazing QA team!
This is a part-time position, with a flexible work schedule. We are reviewing CV's on a continuous basis, so please don't hesitate to apply today with you CV and no later than Sunday October 11. We will be conducting one interview round in October, aiming for a start date on November 1.
Who We Are
AGC Biologics is a global Contract Development and Manufacturing Organization with a strong presence in Denmark. From our Søborg site, we develop and manufacture life‑changing advanced biologics for some of the world’s most innovative pharmaceutical companies. Together with our team members across Europe, the U.S., and Japan, we deliver development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells therapies. Across our global network, we are united by one mission: To work side by side with our customers in order to improve patients’ lives by bringing new biopharmaceuticals to market.